Blocking Molecular 'Cross-Talk' May Prevent Heart Failure
Surgeons at the University of Cincinnati College of Medicine have received $1.5 million to study signaling pathways that may cause heart enlargement (hypertrophy) to progress to heart failure.
Heart failure is a condition in which the heart muscle becomes very weak. It is most often the result of multiple genetic disorders and coronary artery disease, in which plaque builds up inside the arteries, reducing blood flow and starving the heart muscle. As a result, the heart is unable to pump enough oxygen and nutrients to vital organs throughout the body.
According to the American Heart Association, heart failure is the leading cause of hospitalization in adults over 65, and more than 5 million people in the United States suffer from the disease.
Shahab Akhter, MD, a cardiac surgeon and principal investigator for the study, believes that protein kinase Ca molecule that is activated when the heart becomes enlargedturns on a specific enzyme that limits the hearts ability to respond to stress and pump efficiently. This can lead to poor heart function and, ultimately, heart failure.
Dr. Akhter and his team will study the interaction between these two signaling molecules in multiple lines of genetically engineered miceeach designed to express a specific kinase or kinase inhibitorin order to identify new ways to prevent heart function deterioration.
If we can identify and block this molecular cross-talk that contributes to heart failure, we can develop new, more precise therapies that reduce the incidence of disease and save more lives, Dr. Akhter says.
Heart disease is currently treated with a combination of drugs that reduce stress on the heart and improve blood flow. These include ACE (angiotensin-converting enzyme) inhibitors, which reduce blood pressure; beta-blockers, which block receptors to slow the heartbeat and reduce muscle contractions; and diuretics, which help the body remove unneeded water and salt.
Beta-blockers and ACE inhibitors are effective in treating the symptoms of heart failure, but clearly we need to do better. The average survival rate for someone with heart failure is just five years, says Dr. Akhter.
The five-year, basic science study is funded by the National Institutes of Health, National Heart, Lung and Blood Institute and Thoracic Surgery Foundation for Research and Education.
Related Stories
UC study: Brain organ plays key role in adult neurogenesis
July 2, 2024
The University of Cincinnati has published research in the Proceedings of the National Academy of Sciences that found the choroid plexus and cerebrospinal fluid play a key role in maintaining a pool of newly born neurons to repair the adult brain after injury.
Put down that beer; it's not a tanning lotion
July 1, 2024
The University of Cincinnati's Kelly Dobos joined WVXU's Cincinnati Edition to discuss what's fact and what's myth when it comes to sunscreen use, different kinds of sunscreen and a social media recommendation to use beer on your skin to help get a tan.
Cincinnati researchers want to know if MRIs can work better
June 28, 2024
WVXU and the Cincinnati Business Courier highlighted a new collaboration between the University of Cincinnati College of Medicine, UC Health GE HealthCare, JobsOhio, REDI Cincinnati and Cincinnati Children’s to create an MRI Research and Development Center of Excellence located on UC’s medical campus.